Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 83.30
-0.65 (-0.77%)
Aug 19, 2025, 11:45 AM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 45.63 billion as of August 18, 2025. Its market cap has increased by 274.78% in one year.
Market Cap
45.63B
Enterprise Value
48.64B
Revenue
6.09B
Ranking
n/a
PE Ratio
52.26
Stock Price
83.30
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 45.63B, an increase of 71.14%. That is a compound annual growth rate of 9.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 45.63B | 254.22% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | 25.52B | 15.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.65B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 196.01B |
| Innovent Biologics | 166.99B |
| Akeso | 148.55B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.94B |
| CSPC Pharmaceutical Group | 125.31B |